Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Analyst ; 140(15): 5198-204, 2015 Aug 07.
Article in English | MEDLINE | ID: mdl-26086875

ABSTRACT

Despite the accessibility of the oral cavity to clinical examination, delays in diagnosis of oral and oropharyngeal carcinoma (OOPC) are observed in a large majority of patients, with negative impact on prognosis. Diagnostic aids might help detection and improve early diagnosis, but there remains little robust evidence supporting the use of any particular diagnostic technology at the moment. The aim of the present feasibility first-in-human study was to evaluate the preliminary diagnostic validity of a novel technology platform based on dielectrophoresis (DEP). DEP does not require labeling with antibodies or stains and it is an ideal tool for rapid analysis of cell properties. Cells from OOPC/dysplasia tissue and healthy oral mucosa were collected from 57 study participants via minimally-invasive brush biopsies and tested with a prototype DEP platform using median membrane midpoint frequency as main analysis parameter. Results indicate that the current DEP platform can discriminate between brush biopsy samples from cancerous and healthy oral tissue with a diagnostic sensitivity of 81.6% and a specificity of 81.0%. The present ex vivo results support the potential application of DEP testing for identification of OOPC. This result indicates that DEP has the potential to be developed into a low-cost, rapid platform as an assistive tool for the early identification of oral cancer in primary care; given the rapid, minimally-invasive and non-expensive nature of the test, dielectric characterization represents a promising platform for cost-effective early cancer detection.


Subject(s)
Mouth Neoplasms/diagnosis , Mouth/pathology , Oropharyngeal Neoplasms/diagnosis , Oropharynx/pathology , Biopsy , Early Detection of Cancer/methods , Electrophoresis/methods , Humans , Mouth Mucosa/pathology , Mouth Neoplasms/pathology , Oropharyngeal Neoplasms/pathology
2.
Plant Dis ; 99(10): 1326-1332, 2015 Oct.
Article in English | MEDLINE | ID: mdl-30690987

ABSTRACT

The genus Phytophthora contains some of the most notorious plant pathogens affecting nursery crops. Given the recent emergence of the sudden oak death pathogen Phytophthora ramorum, particularly in association with Rhododendron spp., characterization of Phytophthora communities associated with this host in nursery environments is prudent. Many taxa may present symptoms similar to P. ramorum but we do not necessarily know their identity, frequency, and importance. Here, we present a survey of Phytophthora taxa observed from seven nurseries in the U.S. state of Oregon. Incidence and diversity of Phytophthora communities differed significantly among nurseries and among seasons within nursery. The taxa P. syringae and P. plurivora were widespread and detected at most of the nurseries sampled. Nine other taxa were also detected but were found either in a single nursery or were shared among only a few nurseries. Characterization of the Phytophthora communities present in nurseries is an important step toward understanding the ecology of these organisms as well as an aid to nursery managers in determining what risks may be present when symptomatic plants are observed. This study builds on an increasing literature, which characterizes Phytophthora community structure in nurseries.

3.
Early Interv Psychiatry ; 9(5): 397-405, 2015 Oct.
Article in English | MEDLINE | ID: mdl-24612563

ABSTRACT

AIM: Deficient vitamin D levels are very common among Americans of all ages and ethnicities, but little is known about its prevalence or associated problems among those with schizophrenia. METHODS: Stored plasma from 20 recent onset schizophrenia subjects and 20 matched healthy comparison subjects were analysed for 25 OH vitamin D, and related to measures of symptom severity and neurocognition. RESULTS: There was no significant difference in mean 25 OH vitamin D between the schizophrenia and the healthy comparison subjects (28.2 standard deviation (SD) 12.6 ng mL(-1) vs. 29.9 SD 14.3 ng mL(-1) ), and about half the subjects in each group had insufficient levels (<30 ng mL(-1) ). Among psychosis subjects, greater severity of negative symptoms was correlated with lower vitamin D status (r = -0.55, P = 0.012); the correlations of overall symptom severity and positive symptom severity with 25 OH vitamin D levels approached significance (r = -0.42, P = 0.07 and r = -0.36, P = 0.12, respectively). There was no relationship of vitamin D with depressive symptoms. Among the schizophrenia subjects, lower 25 OH vitamin D levels were associated with more severe overall cognitive deficits (r = 0.56, P = 0.019). CONCLUSION: This study found that lower vitamin D levels in schizophrenia subjects were associated with more severe negative symptoms and overall cognitive deficits. However, the cross-sectional design precludes any conclusions about whether low vitamin D status in fact causes more severe negative symptoms and cognitive impairments. No relationship was found between lower vitamin D levels and depressive symptoms.


Subject(s)
Cognition Disorders/complications , Cognition Disorders/psychology , Schizophrenia/complications , Schizophrenic Psychology , Vitamin D Deficiency/complications , Vitamin D Deficiency/psychology , Vitamin D/blood , Case-Control Studies , Cognition Disorders/blood , Cross-Sectional Studies , Depression/blood , Depression/complications , Depression/psychology , Female , Humans , Male , Neuropsychological Tests , Schizophrenia/blood , Schizophrenia/diagnosis , Vitamin D Deficiency/blood , Young Adult
4.
Integr Biol (Camb) ; 6(5): 545-54, 2014 May.
Article in English | MEDLINE | ID: mdl-24663430

ABSTRACT

OBJECTIVE: Although cells with tumorigenic/stem cell-like properties have been identified in many cancers, including oral squamous cell carcinoma (OSCC), their isolation and characterisation is still at early stages. The aim of this study is to characterise the electrophysiological properties of OSCC cells with different tumorigenic properties in order to establish if a correlation exists between tumorigenicity and cellular electrical characteristics. MATERIALS AND METHODS: Rapid adherence to collagen IV was used as a non-invasive, functional method to isolate subsets of cells with different tumorigenic abilities from one oral dysplastic and three OSCC-derived cell lines. The cell subsets identified and isolated using this method were further investigated using dielectrophoresis, a label-free method to determine their electrophysiological parameters. Cell membrane morphology was investigated using scanning electron microscopy (SEM) and modulated by use of 4-methylumbelliferone (4-MU). RESULTS: Rapid adherent cells (RAC) to collagen IV, enriched for increased tumorigenic ability, had significantly higher effective membrane capacitance than middle (MAC) and late (LAC) adherent cells. SEM showed that, in contrast to MAC and LAC, RAC displayed a rough surface, extremely rich in cellular protrusions. Treatment with 4-MU dramatically altered RAC membrane morphology by causing loss of filopodia, and significantly decreased their membrane capacitance, indicating that the highest membrane capacitance found in RAC was due to their cell membrane morphology. CONCLUSION: This is the first study showing that OSCC cells with higher tumour formation ability exhibit higher effective membrane capacitance than cells that are less tumorigenic. OSSC cells with different tumorigenic ability possessed different electrophysiological properties mostly due to their differences in the cell membrane morphology. These results suggest that dielectrophoresis could potentially used in the future for reliable, label-free isolation of putative tumorigenic cells.


Subject(s)
Carcinoma, Squamous Cell/pathology , Cell Membrane/pathology , Mouth Neoplasms/pathology , Neoplastic Stem Cells/pathology , Animals , Carcinoma, Squamous Cell/ultrastructure , Cell Adhesion/physiology , Cell Line, Tumor , Cell Membrane/ultrastructure , Electric Capacitance , Humans , Hymecromone/pharmacology , Mice, Inbred NOD , Mice, SCID , Microscopy, Electron, Scanning , Mouth Neoplasms/ultrastructure , Neoplastic Stem Cells/ultrastructure , Specific Pathogen-Free Organisms
5.
Neuroscience ; 164(4): 1484-95, 2009 Dec 29.
Article in English | MEDLINE | ID: mdl-19744544

ABSTRACT

Glial activation and neuroinflammation occur in neurodegenerative disease and brain injury, however their presence in normal brain aging suggests that chronic neuroinflammation may be a factor in age-related dementia. Few studies have investigated the impact of sustained elevation of hippocampal interleukin-1beta, a pro-inflammatory cytokine upregulated during aging and Alzheimer's disease, on cognition in mice. We utilized the IL-1beta(XAT) transgenic mouse to initiate bilateral hippocampal overexpression of interleukin-1beta to determine the influence of sustained neuroinflammation independent of disease pathology. Fourteen days following transgene induction, adult male and female IL-1beta(XAT) mice were tested on non-spatial and spatial versions of the Morris water maze. For the spatial component, one retention trial was conducted 48 h after completion of a 3 day acquisition protocol (eight trials per day). Induction of IL-1beta did not impact non-spatial learning, but was associated with delayed acquisition and decreased retention of the spatial task. These behavioral impairments were accompanied by robust reactive gliosis and elevated mRNA expression of inflammatory genes in the hippocampus. Our results suggest that prolonged neuroinflammation response per se may impact mnemonic processes and support the future application of IL-1beta(XAT) transgenic mice to investigate chronic neuroinflammation in age- and pathology-related cognitive dysfunction.


Subject(s)
Hippocampus/metabolism , Interleukin-1beta/biosynthesis , Memory , Spatial Behavior , Animals , Female , Humans , Interleukin-1beta/genetics , Male , Mice , Mice, Transgenic
6.
Eur J Clin Invest ; 32(7): 488-92, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12153548

ABSTRACT

BACKGROUND: In chronic renal failure, metabolic acidosis is associated with increased whole body protein degradation. In rats this effect of acidosis occurs in skeletal muscle and is associated with increased ubiquitin mRNA expression. This has not been demonstrated in humans. MATERIALS AND METHODS: Six patients with chronic renal failure and acidosis underwent muscle biopsy before and after 1 month's treatment with sodium bicarbonate. RNA was extracted from the biopsy, and the expression of the genes for ubiquitin and the proteasome component, C2, were measured by Northern blotting. RESULTS AND CONCLUSIONS: There was no significant difference in the expression of ubiquitin or C2 after bicarbonate treatment. This is contrast with results from animal models of acidosis and some other catabolic conditions in humans. This may reflect the complexity of the ubiquitin-dependent pathway, and it may be that changes in ubiquitin expression are only seen with more severe and/or acute changes in pH.


Subject(s)
Kidney Failure, Chronic/drug therapy , Muscle, Skeletal/metabolism , RNA/analysis , Sodium Bicarbonate/therapeutic use , Ubiquitin/genetics , Acidosis/drug therapy , Adult , Biopsy , Blotting, Northern/methods , Complement C2/genetics , Female , Gene Expression , Humans , Kidney Failure, Chronic/metabolism , Male , Middle Aged , Sodium Bicarbonate/metabolism , Treatment Failure
8.
Int J Artif Organs ; 24(4): 192-6, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11394698

ABSTRACT

In an observational study, nine hemodialysis patients using 35 mmol/l bicarbonate dialysate were studied over a 44-hour interdialytic interval. Serum bicarbonate was measured at regular intervals at home and the mean time averaged concentration was 27.0+/-1.2 mmol/l. Seven of the nine patients showed a slow linear decline in bicarbonate whilst in two patients levels were unchanged. In 8 of 9 patients the average of the post and predialysis bicarbonate accurately predicted the time-averaged (area under the curve) bicarbonate concentration. In addition, predialysis serum bicarbonate was measured in 46 patients after both a 2 and 3-day interdialytic interval. The serum bicarbonate was significantly lower after the 3-day interdialytic interval (3-day, 22.1+/-0.6 vs 2-day, 23.0+/-0.5 mmol/l, p<0.05). The results from this study emphasize the importance of standardization of bicarbonate measurement in order to avoid spurious acidosis.


Subject(s)
Acidosis/blood , Bicarbonates/blood , Kidney Failure, Chronic/blood , Renal Dialysis , Adult , Aged , Bicarbonates/therapeutic use , Dialysis Solutions/therapeutic use , Female , Humans , Kidney Failure, Chronic/therapy , Linear Models , Male , Middle Aged , Time Factors
9.
Article in English | MEDLINE | ID: mdl-10772724

ABSTRACT

The transportability of cytosine-containing nucleosides by recombinant hCNT1 was investigated in transfected mammalian cells. Apparent K(m) values for hCNT1-mediated transport of uridine, cytidine and deoxycytidine were, respectively, 59, 140 and 150 microM. Uridine transport was inhibited 89, 32 and 11%, respectively, by 500 microM gemcitabine, cytarabine and lamivudine, demonstrating that, unlike gemcitabine (a high-affinity hCNT1 permeant), cytarabine and lamivudine are poor hCNT1 permeants.


Subject(s)
Carrier Proteins/metabolism , Cytidine/metabolism , Deoxycytidine/metabolism , Membrane Transport Proteins , Uridine/metabolism , Animals , Antimetabolites, Antineoplastic/pharmacology , Antiviral Agents/pharmacology , Biological Transport , COS Cells , Cell Division/drug effects , Cell Line , Cytarabine/pharmacology , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacology , Haplorhini , HeLa Cells , Humans , Immunoblotting , Lamivudine/pharmacology , Recombinant Proteins/metabolism , Substrate Specificity , Transfection , Gemcitabine
10.
Pharm Biotechnol ; 12: 313-52, 1999.
Article in English | MEDLINE | ID: mdl-10742981

ABSTRACT

In this review, we have summarized recent advances in our understanding of the biology of nucleoside transport arising from new insights provided by the isolation and functional expression of cDNAs encoding the major nucleoside transporters of mammalian cells. Nucleoside transporters are required for permeation of nucleosides across biological membranes and are present in the plasma membranes of most cell types. There is growing evidence that functional nucleoside transporters are required for translocation of nucleosides between intracellular compartments and thus are also present in organellar membranes. Functional studies during the 1980s established that nucleoside transport in mammalian cells occurs by two mechanistically distinct processes, facilitated diffusion and Na(+)-nucleoside cotransport. The determination of the primary amino acid sequences of the equilibrative and concentrative transporters of human and rat cells has provided a structural basis for the functional differences among the different transporter subtypes. Although nucleoside transporter proteins were first purified from human erythrocytes a decade ago, the low abundance of nucleoside transporter proteins in membranes of mammalian cells has hindered analysis of relationships between transporter structure and function. The molecular cloning of cDNAs encoding nucleoside transporters and the development of heterologous expression systems for production of recombinant nucleoside transporters, when combined with recombinant DNA technologies, provide powerful tools for characterization of functional domains within transporter proteins that are involved in nucleoside recognition and translocation. As relationships between molecular structure and function are determined, it should be possible to develop new approaches for optimizing the transportability of nucleoside drugs into diseased tissues, for development of new transport inhibitors, including reagents that are targeted to the concentrative transporters, and, eventually, for manipulation of transporter function through an understanding of the regulation of transport activity.


Subject(s)
Carrier Proteins/metabolism , Nucleosides/metabolism , Animals , Antineoplastic Agents/metabolism , Antiviral Agents/metabolism , Biological Transport , Carrier Proteins/classification , Cell Membrane/metabolism , Humans , Intracellular Membranes/metabolism , Mammals , Receptors, Purinergic/metabolism
11.
J Biol Chem ; 273(46): 30818-25, 1998 Nov 13.
Article in English | MEDLINE | ID: mdl-9804860

ABSTRACT

The equilibrative nucleoside transporters (ENTs) are a newly recognized family of membrane proteins of which hENT1 is the nitrobenzylmercaptopurine ribonucleoside (NBMPR)-sensitive (es) and hENT2 the NBMPR-insensitive (ei) transporter of human cells. BeWo cells exhibit large numbers (>10(7)/cell) of NBMPR-binding sites and high es and ei nucleoside transport activities relative to other cell types. In this work, we have demonstrated that proliferating BeWo cells possess (i) mRNA encoding hENT1 and hENT2 and (ii) hENT1-specific immunoepitopes. We examined NBMPR binding and its inhibition of uridine transport in various BeWo membrane fractions and proteoliposomes derived therefrom to determine if NBMPR binding to intracellular membranes represented interaction with functional es transporters. Unfractionated membranes and fractions enriched 5-fold in plasma membranes relative to postnuclear supernatants exhibited high NBMPR binding activity. Intact nuclei and nuclear envelopes also exhibited abundant quantities of NBMPR-binding sites with affinities similar to those of enriched plasma membranes (Kd = 0.4-0.9 nM). When proteoliposomes were made from octyl glucoside-solubilized membranes, high affinity NBMPR-binding sites were not only observed in crude membrane preparations and plasma membrane-enriched fractions but also in nuclear envelope fractions. Proteoliposomes prepared from either unfractionated membranes or nuclear envelopes exhibited both hENT1-mediated (82-85%) and hENT2-mediated (15-18%) transport of [3H]uridine. These results provided evidence for the presence of functional es and ei transporters in nuclear membranes and endoplasmic reticulum, suggesting that hENT1 and hENT2 may function in the translocation of nucleosides between the cytosol and the luminal compartments of one or both of these membrane types.


Subject(s)
Carrier Proteins/analysis , Choriocarcinoma/chemistry , Equilibrative-Nucleoside Transporter 2 , Membrane Proteins/analysis , Nuclear Envelope/chemistry , Proteolipids/metabolism , Affinity Labels/metabolism , Binding Sites , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Membrane/metabolism , Cell Nucleus/metabolism , Equilibrative Nucleoside Transporter 1 , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , RNA, Messenger/metabolism , Thioinosine/analogs & derivatives , Thioinosine/metabolism , Tumor Cells, Cultured , Uridine/metabolism
12.
J Air Waste Manag Assoc ; 48(2): 106-12, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9517320

ABSTRACT

Submicrometer ash and sulfur oxides are important pollutants formed during pulverized coal combustion. The submicrometer ash contains known catalysts for sulfur dioxide oxidation as well as alkaline species that will react with sulfur oxides. This work was an investigation to determine if submicrometer ash-sulfur oxide interactions can have a significant impact on the fate of sulfur. The submicrometer-ash-sulfur oxide interaction studies were carried out using submicrometer ash of controlled composition generated from the combustion of synthetic chars. The submicrometer ash was either exposed to SO2 in the combustion chamber or immobilized on a quartz-fiber filter for later exposure to SO2. Submicrometer-ash catalysis of SO2 oxidation was found to contribute significantly to the SO3 formed in the convective passes of a utility boiler, depending on the coal, combustion conditions, and temperature profile in the convective section. The calcium within the freshly formed submicrometer ash appears to sulfate more rapidly than would be predicted from rates published in the literature and is expected to sulfate completely in the convective section of a utility boiler.


Subject(s)
Air Pollutants, Occupational/chemistry , Sulfuric Acids/chemistry , Aerosols
13.
J Am Soc Nephrol ; 8(4): 632-7, 1997 Apr.
Article in English | MEDLINE | ID: mdl-10495793

ABSTRACT

Correction of acidosis in hemodialysis (HD) decreases protein degradation. The effect of the correction of chronic metabolic acidosis in chronic renal failure patients treated with HD was determined from the kinetics of infused L-[1-(13)C]leucine. Six HD patients were studied before (acid) and after (bicarbonate) correction of acidosis (pH: acid 7.36 +/- 0.01, bicarbonate 7.40 +/- 0.01, P < 0.005). Leucine appearance from body protein (PD) and leucine disappearance into body protein (PS) decreased significantly with correction of acidosis (PD: acid 180.6 +/- 7.3, bicarbonate 130.9 +/- 7.2 mumol.kg-1.h-1, P < 0.005; PS: acid 172.3 +/- 6.8, bicarbonate 122.0 +/- 6.8 mumol.kg-1.h-1, P < 0.005). There was no significant change in leucine oxidation or plasma amino acid concentrations. These results demonstrate that optimal correction of acidosis in HD is beneficial in terms of protein turnover and may improve long-term nutritional status in HD.


Subject(s)
Acidosis/blood , Blood Proteins/metabolism , Kidney Failure, Chronic/blood , Leucine/blood , Renal Dialysis/adverse effects , Acidosis/drug therapy , Acidosis/etiology , Adult , Aged , Amino Acids/blood , Bicarbonates/therapeutic use , Body Composition , Body Mass Index , Dietary Carbohydrates/administration & dosage , Dietary Proteins/administration & dosage , Female , Humans , Infusions, Intravenous , Kidney Failure, Chronic/therapy , Leucine/administration & dosage , Male , Urea/blood
14.
J Am Soc Nephrol ; 8(4): 627-31, 1997 Apr.
Article in English | MEDLINE | ID: mdl-10495792

ABSTRACT

Correction of acidosis in hemodialysis patients increases the sensitivity of the parathyroid glands to calcium. In this study, the parathyroid response to the correction of acidosis in eight hemodialysis patients was determined by performing dynamic assessment of parathyroid function before and after the correction of acidosis. The parathyroid response to intravenous calcitriol before and after the correction of acidosis was also assessed. After optimal correction of acidosis, there were no significant changes in blood pH, ionized calcium, phosphate, or alkaline phosphatase values, but the level of venous total CO2 increased significantly. Parathyroid hormone/ionized calcium curves were displaced downward after correction of acidosis, but not after the administration of intravenous calcitriol. The correction of metabolic acidosis in hemodialysis patients with secondary hyperparathyroidism can suppress parathyroid hormone secretion by increasing the sensitivity of the parathyroid glands to ionized calcium.


Subject(s)
Acidosis/metabolism , Calcium/metabolism , Hyperparathyroidism, Secondary/metabolism , Parathyroid Glands/metabolism , Renal Dialysis/adverse effects , Acidosis/etiology , Adult , Calcium/blood , Carbon Dioxide/blood , Female , Humans , Hydrogen-Ion Concentration , Hyperparathyroidism, Secondary/etiology , Male , Middle Aged , Phosphates/blood , Vitamin D/analogs & derivatives , Vitamin D/blood
15.
Virology ; 229(1): 12-24, 1997 Mar 03.
Article in English | MEDLINE | ID: mdl-9123853

ABSTRACT

Immunomodulatory proteins encoded by the larger DNA viruses interact with a wide spectrum of immune effector molecules that regulate the antiviral response in the infected host. Here we show that certain poxviruses, including myxoma virus. Shope fibroma virus, rabbitpox virus, vaccinia virus (strain Lister), cowpox virus, and raccoonpox virus, express a new family of secreted proteins which interact with members of both the CC and CXC superfamilies of chemokines. However, swinepox virus and vaccinia virus (strain WR) do not express this activity Using a recombinant poxviruses, the myxoma M-T1 and rabbitpox virus 35kDa secreted proteins were identified as prototypic members of this family of chemokine binding proteins. Members of this T1/35kDa family of poxvirus-secreted proteins share multiple stretches of identical sequence motifs, including eight conserved cysteine residues, but are otherwise unrelated to any cellular genes in the database. The affinity of the CC chemokine RANTES interaction with M-T1 was assessed by Scatchard analysis and yielded a Kd of approximately 73 nM. In rabbits infected with a mutant rabbitpox virus, in which the 35kDa gene is deleted, there was an increased number of extravasating leukocytes in the deep dermis during the early phases of infection. These observations suggest that members of the T1/35kDa class of secreted viral proteins bind multiple members of the chemokine superfamily in vitro and modulate the influx of inflammatory cells into virus-infected tissues in vivo.


Subject(s)
Carrier Proteins/metabolism , Chemokines/metabolism , Leukocytes/cytology , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Animals , Base Sequence , Carrier Proteins/genetics , Cell Line , Chemotaxis, Leukocyte , Chlorocebus aethiops , DNA, Viral , Female , Molecular Sequence Data , Protein Binding , Rabbits , Sequence Homology, Amino Acid , Viral Nonstructural Proteins/genetics
16.
Kidney Int ; 49(5): 1396-400, 1996 May.
Article in English | MEDLINE | ID: mdl-8731105

ABSTRACT

Correction of acidosis in CAPD decreases protein degradation and synthesis but has no effect on leucine oxidation. The effect of the correction of metabolic acidosis in CRF patients treated with CAPD was determined from the kinetics of infused L-[1-13C]leucine. Seven CAPD patients were studied before (acid) and after correction of acidosis (bicarbonate) (pH:acid 7.39 +/- 0.01, bicarbonate 7.41 +/- 0.01, P = 0.005). Leucine appearance from body protein (PD) [corrected] and leucine disappearance into body protein (PS) [corrected] decreased significantly with correction of acidosis. (PS: acid 211.7 +/- 9.8, bicarbonate 142.3 +/- 4.2 micromol x kg-1 x hr-1, P < 0.001; PD: acid 200.6 +/- 8.5, bicarbonate 132.4 +/- 3.7 micromol x kg-1 x hr-1, P < 0.001). There was no significant change in leucine oxidation or plasma amino acid concentrations. These results demonstrate that optimal correction of acidosis in CAPD is beneficial in terms of protein turnover.


Subject(s)
Acidosis/metabolism , Acidosis/therapy , Peritoneal Dialysis, Continuous Ambulatory , Proteins/metabolism , Acidosis/etiology , Adult , Amino Acids/blood , Blood Pressure , Body Weight , Female , Humans , Hydrogen-Ion Concentration , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/metabolism , Kidney Failure, Chronic/therapy , Kinetics , Leucine/metabolism , Male , Middle Aged , Urea/blood
17.
Virology ; 218(1): 232-7, 1996 Apr 01.
Article in English | MEDLINE | ID: mdl-8615027

ABSTRACT

Myxoma virus is a leporipoxvirus that causes a highly lethal virulent disease known as myxomatosis in the European rabbit. An important aspect of myxoma virus pathogenesis is the ability of the virus to productively infect lymphocytes and spread to secondary sites via lymphatic channels. We investigated the infection of the CD4+ T lymphoma cell line RL-5 with myxoma virus and Shope fibroma virus, a related but benign leporipoxvirus, and observed that myxoma virus, but not Shope fibroma virus, was able to productively infect RL-5 cells. We also discovered that infection of RL-5 cells with Shope fibroma virus or attenuated myxoma virus mutants containing disruptions in either the T2 or the M11L gene resulted in the rapid induction of DNA fragmentation, followed by morphological changes and loss in cell integrity characteristic of cell death by apoptosis. Purified exogenous T2 protein was unable to prevent apoptosis, suggesting that T2 functions intracellularly. Thus, myxoma virus T2, originally described as a secreted homologue of the tumor necrosis factor receptor, and M11L, a novel transmembrane species with no known cellular homologue, function to extend virus host range for replication in rabbit T lymphocytes through the inhibition of apoptosis in infected T lymphocytes.


Subject(s)
Apoptosis , CD4-Positive T-Lymphocytes/virology , Myxoma virus/physiology , Receptors, Tumor Necrosis Factor/physiology , Viral Proteins/physiology , Animals , CD4-Positive T-Lymphocytes/metabolism , DNA Damage , Fibroma Virus, Rabbit/genetics , Fibroma Virus, Rabbit/physiology , Gene Expression , Myxoma virus/genetics , Myxoma virus/pathogenicity , Rabbits , Receptors, Tumor Necrosis Factor/genetics , Serpins/genetics , Serpins/physiology , Tumor Cells, Cultured , Viral Proteins/genetics
18.
Nephrol Dial Transplant ; 11(1): 133-9, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8649621

ABSTRACT

BACKGROUND: Termination of renal replacement therapy (RRT) is common in North America and Australia but is considered to be rare in Europe. METHODS: In order to review the phenomenon of RRT termination in all patients treated in Newcastle upon Tyne between 1964 and 1993 a retrospective study of clinical case notes was undertaken. In all RRT patients sex, age at start of RRT, renal diagnosis and history of RRT were recorded. In addition, mortality data and marital and residential status were recorded in all patients who died, and Karnofsky index, bodyweight, complications, history of bereavement, place of death, overall survival, survival after withdrawal of treatment, other medical problems, higher mental function and surgical history in all patients stopping treatment. RESULTS: 1639 patients started RRT between 1964 and September 1993 inclusive. Eighty-eight patients were identified in whom death was a result of treatment being stopped (17% of all deaths). The first was in 1985. In these patients, age was greater (62 vs 47 years, P < 0.001) and diabetes was more prevalent (15 vs 7%, P < 0.03) than in the total RRT population. The Karnofsky index was 70 at the start and 33 at withdrawal of treatment (P < 0.001). The Karnofsky index at the start of RRT was weakly related to that at withdrawal and overall survival (r = 0.36 and 0.28 respectively, P < 0.01). The Karnofsky index at treatment withdrawal correlated with the following survival (r = 0.40, P < 0.001). The median survival of patients stopping treatment was significantly lower than in all RRT patients (16 vs 74 months, P < 0.001) and the majority survived less than 2 years. After dialysis withdrawal the median survival was 8 days, 15 patients survived 3 days or less and 19 more than 10 days. The majority (80%) received terminal care in hospital. At treatment withdrawal 11 patients were demented and 34 showed signs of early dementia. Seventy-eight patients (89%) stopped treatment as a consequence of multiple medical problems. The possibility of dialysis withdrawal was raised by physicians in 50.5%, the patient in 23.8% and the patients' relatives in 21.9% of cases. Four patients (3.8%) committed suicide. CONCLUSIONS: Death from dialysis termination is a relatively common cause of death in RRT patients in Newcastle upon Tyne. These patients are older with a higher prevalence of diabetes. In 89% of cases the decision to stop treatment was related to multiple medical problems with a recent deterioration. Physicians raised the issue of withdrawal in the majority of cases and most patients subsequently received terminal care in hospital.


Subject(s)
Kidney Failure, Chronic/mortality , Renal Replacement Therapy , Withholding Treatment , Decision Making , Female , Hospitalization , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Middle Aged , Patient Selection , Retrospective Studies , Survival Rate , Treatment Refusal , United Kingdom/epidemiology
19.
Am J Physiol ; 268(1 Pt 1): E121-6, 1995 Jan.
Article in English | MEDLINE | ID: mdl-7840169

ABSTRACT

To test the hypothesis that acidosis contributes to the insulin resistance of chronic renal failure (CRF) and impairs the action of insulin to decrease protein degradation, eight CRF patients were studied using the combined L-[1-13C]leucine-euglycemic clamp technique before (acid) and after (NaHCO3) 4 wk treatment with NaHCO3 (pH: acid 7.29 +/- 0.01 vs. NaHCO3 7.36 +/- 0.01, P < 0.001). Protein degradation (PD) was estimated sequentially from the kinetics of a primed continuous infusion of L-[1-13C]leucine in the basal state and during a hyperinsulinemic euglycemic clamp. Insulin sensitivity was measured during the clamp. The correction of acidosis significantly increased the glucose infusion rate necessary to maintain euglycemia (acid 6.44 +/- 0.89 vs. bicarbonate 7.38 +/- 0.90 mg.kg-1.min-1, P < 0.01) and significantly decreased PD in the basal state (acid 126.4 +/- 8.1 vs. bicarbonate 100.1 +/- 6.9 mumol.kg-1.h-1, P < 0.001). Hyperinsulinemia decreased PD in both studies (acid basal 126.4 +/- 8.1 vs. clamp 96.5 +/- 7.7, P < 0.001; bicarbonate basal 100.1 +/- 6.9 vs. clamp 88.2 +/- 5.5 mumol.kg-1.h-1, P = 0.06), its effect being unaltered by acidosis, with a reduction of 24% before and 12% after the correction of acidosis. In conclusion, acidosis contributes to the insulin resistance of CRF but does not affect the action of insulin on PD.


Subject(s)
Acidosis/drug therapy , Acidosis/etiology , Amino Acids/metabolism , Glucose/metabolism , Kidney Failure, Chronic/complications , Adult , Aged , Bicarbonates/blood , Blood Pressure , Body Weight , Female , Glucose Clamp Technique , Humans , Hydrogen-Ion Concentration , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/physiopathology , Leucine/pharmacokinetics , Male , Middle Aged , Sodium Bicarbonate/therapeutic use
20.
Kidney Int Suppl ; 48: S47-50, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7700041

ABSTRACT

To prevent increased protein degradation and renal bone disease, optimal correction of acidosis should therefore be a priority in the management of CAPD patients. Initial results suggest that bicarbonate solutions may be more biocompatible than lactate, and one would expect increasing use over the next decade. Manufacturers could help to improve acid-base regulation in CAPD by providing a range of solutions with varying lactate and bicarbonate concentration, so that correction of acidosis could be optimized individually.


Subject(s)
Acid-Base Imbalance/therapy , Kidney Failure, Chronic/complications , Peritoneal Dialysis, Continuous Ambulatory/methods , Acid-Base Equilibrium/physiology , Acid-Base Imbalance/etiology , Acid-Base Imbalance/physiopathology , Bicarbonates/therapeutic use , Bone Diseases, Metabolic/etiology , Dialysis Solutions/therapeutic use , Humans , Hyperparathyroidism, Secondary/etiology , Lactates/therapeutic use , Protein Deficiency/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...